Coastline Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Coastline Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-110	Closed	-$17.4K	–	401
2026 Q2	$17.4K	Hold	110	–	–	﹤0.01%	329
2026 Q1	$14.1K	Buy	110 +40	+57%	+$4.99K	﹤0.01%	338
2025 Q4	$8.54K	Buy	+70	New	+$8.03K	﹤0.01%	362
2016 Q1	–	Sell	-3,000	Closed	-$211K	–	262
2015 Q4	$211K	Buy	+3,000	New	+$205K	0.05%	253
2015 Q3	–	Sell	-3,000	Closed	-$252K	–	265
2015 Q2	$252K	Hold	3,000	–	–	0.05%	246
2015 Q1	$226K	Sell	3,000 -3,000	-50%	-$210K	0.05%	254
2014 Q4	$372K	Buy	+6,000	New	+$342K	0.08%	226

Other funds holding XBI

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BCG

Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

BONH

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

VAG

VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

WAM

Worth Asset Management Dallas, Texas $343M AUM 29.82% 1-Year Est. Return

Coastline Trust's XBI Position: Q3 2026 in Review

Coastline Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 110 shares — an estimated $17.4K sold.

Coastline Trust first reported a position in XBI in Q4 2014 and held it in 7 quarters. The position peaked at $372K in Q4 2014. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Coastline Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
Coastline Trust sold 110 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $17.4K.
Coastline Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and held it in 7 quarters.
Coastline Trust's State Street SPDR S&P Biotech ETF position peaked at $372K in Q4 2014.
39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Coastline Trust's 13F filing for Q3 2026, filed 1 Oct 2026.